"Isabelle is first joined by Gabriel Sanchez, the CEO and co-founder of Enspectra Health. The company has built a device that aims to do away with the need for dermatologist skin biopsies. Sanchez breaks down his decade-long journey to receiving FDA clearance. Throughout the interview, Sanchez offers tactical advice to anyone in the midst of a long regulatory process and explains how he's kept his company afloat and his team motivated despite the uncertainties."
"Next, Isabelle speaks with Tom Harries, the co-founder of Earth Funeral, an end-of-life startup that has developed a new process that transforms human remains into soil. Harries didn't have to lead his team through a long FDA approval process (because the FDA is primarily concerned with the living), but his company has faced its own legislative challenges. Earth Funeral launched at a time when its alternative process was only legal in one state."
Building in regulated industries significantly increases startup difficulty due to elongated timelines and complex approval processes. Enspectra Health created a device intended to eliminate dermatologist skin biopsies and pursued FDA clearance over a decade. The CEO shared tactical advice for navigating prolonged regulatory processes and described strategies for maintaining company finances and team motivation amid uncertainty. Earth Funeral developed a process that transforms human remains into soil and faced legislative challenges because its alternative method was legal in only one state at launch. Expansion for Earth Funeral depends on legislative change and public acceptance rather than agency accreditation.
Read at TechCrunch
Unable to calculate read time
Collection
[
|
...
]